Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management

Last updated: November 23, 2025
Sponsor: Shanxi Bethune Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 2

Treatment

Integrated TCM-Western Medicine Intelligent Diabetes Management Platform

Clinical Study ID

NCT07265037
YXLL-2025-260
  • Ages > 18
  • All Genders

Study Summary

The management of diabetes is of great value in reducing the risk of complications and alleviating the socioeconomic burden. Currently, the diabetes management models in China have not effectively integrated the advantages of traditional Chinese medicine (TCM) and Western medicine. They also fail to achieve intelligent and automated management, resulting in high management costs and low efficiency. Therefore, it is extremely urgent to explore a new, efficient, convenient, low - cost, and personalized long - distance, full - course, intelligent management model for diabetes that integrates TCM and Western medicine both online and offline.

Based on this, our research group plans to rely on the pre - designed and developed Idata database. We will deeply integrate the diagnostic and treatment advantages of TCM constitution differentiation and Western medical examinations and laboratory tests, construct an automated follow - up path, and build an integrated online diabetes management platform for Internet hospitals, which consists of "intelligent hardware + APP

  • cloud services + a back - end think - tank of TCM and Western medicine experts + a back
  • end professional management and care team".

This initiative aims to blaze a new trail in the field of long - distance, full - course, and personalized management of diabetes through the synergy of TCM and Western medicine for Chinese diabetes patients. We expect to significantly reduce the incidence of diabetes complications, remarkably improve the overall health status and quality of life of patients, and bring unprecedented positive impacts on the well - being of diabetes patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Presence of typical diabetes symptoms (polyuria, polydipsia, polyphagia, andunexplained weight loss) AND meeting any one of the following laboratory criteria:Fasting venous plasma glucose ≥ 7.0 mmol/L, or Random plasma glucose ≥ 11.1 mmol/L,or Glycated hemoglobin (HbA1c) ≥ 6.5%.

  • OR, meeting the following oral glucose tolerance test criteria:Fasting plasmaglucose ≥ 7.0 mmol/L AND 2-hour plasma glucose ≥ 11.1 mmol/L after a 75g glucoseload.

Exclusion

Exclusion Criteria:

  • Comorbidities that may prevent compliance with the study protocol, including but notlimited to: active malignancy, rheumatic autoimmune diseases, severe infections,multiple organ failure, or psychiatric disorders.

Study Design

Total Participants: 10000
Treatment Group(s): 1
Primary Treatment: Integrated TCM-Western Medicine Intelligent Diabetes Management Platform
Phase:
Study Start date:
November 01, 2025
Estimated Completion Date:
May 31, 2026

Connect with a study center

  • Shanxi Bethune Hospital

    Taiyuan 1793511, Shanxi 1795912 030000
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.